Evidence map›Paper›PMID 42638189›Full record

ArticleCA: a cancer journal for clinicians

Discordant molecular biomarkers in unfavorable intermediate-risk localized prostate cancer.

Michael Rooney, Krishnan R Patel, Shalin Shah, Justin R Gregg, Steven Jay Frank, Karen Hoffman, Ryan Park, Comron J Hassanzadeh, Seungtaek Choi, Sean McGuire and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in CA: a cancer journal for clinicians. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Michael RooneyDivision of Radiation Oncology, Department of Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-2860-4653
Krishnan R PatelDivision of Radiation Oncology, Department of Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0003-2120-1939
Shalin ShahDivision of Radiation Oncology, Department of Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-1622-8443
Justin R GreggDivision of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Steven Jay FrankDivision of Radiation Oncology, Department of Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0001-6517-7884
Karen HoffmanDivision of Radiation Oncology, Department of Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-7316-8790
Ryan ParkDivision of Radiation Oncology, Department of Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0003-4725-2937
Comron J HassanzadehDivision of Radiation Oncology, Department of Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-8107-2799
Seungtaek ChoiDivision of Radiation Oncology, Department of Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Sean McGuireDivision of Radiation Oncology, Department of Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Quynh-Nhu NguyenDivision of Radiation Oncology, Department of Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Daniel N CostaDivision of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-2890-5720
Patricia TroncosoDivision of Pathology and Laboratory Medicine, Department of Pathology-Anatomical, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-8241-1430
Sumit K SubudhiDivision of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0001-5208-7732
Shuang George ZhaoDepartment of Human Oncology, University of Wisconsin, Madison, Wisconsin, USA.
Curtis A PettawayDivision of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0003-1697-1840
Paul CornDivision of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-4106-6335
Chad TangDivision of Radiation Oncology, Department of Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-5915-1327
Phuoc T TranDivision of Radiation Oncology, Department of Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-0147-0376

Funding

Resource Sharing CoreU54CA273956 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI Phuoc T. Tran · 2022 to 2026
$8.9M
Tumor-barcoding coupled with high-throughput sequencing for quantitative radiogenomics of the abscopal response in NSCLCR01CA271540 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Phuoc T. Tran · 2023 to 2026
$2.3M
Integrated Clinical-Grade genomic and pathology AI biomarkers for high-risk prostate cancerR01CA299863 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Paul L Nguyen, Shuang Zhao · 2025 to 2026
$1.2M
American Society of Clinical Oncology Foundation and Conquer CancerAnonymous DonorNCI NIH HHS R01 CA271540NCI NIH HHS R01 CA299863NCI NIH HHS U54 CA273956NIH HHS 1R01CA271540NIH HHS 1R01CA299863NIH HHS U54CA273956Prostate Cancer Foundation
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42638189
PMCPMC13503972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.